Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Editor’s Picks: Gold Faces Bumpy Week on Trade Tensions, Platinum Stages Breakout June 1, 2025 NVIDIA Rallies After Strong Q1, AI Demand Outshines China Export Hit May 31, 2025 Top 5 Canadian Mining Stocks This Week: Adyton Sparkles with 97 Percent Gain May 31, 2025